LABIOTECH.fr: Acticor Biotech wins its crowdfunding bet!

/in , /by

Acticor Biotech réussi le pari du crowdfunding!
By Joachim – Published on January 29, 2015 | LABIOTECH.fr

Read the article in French : http://labiotech.fr/acticor-biotech-reussi-le-pari-du-crowdfunding/


Read also in English : Biotech’s crowdfunding: is France top of the class?
“In France, you can feel a real enthousiasme for crowdfunding and many projects are running on different platforms. I met several companies currently fundraising to understand their reasons and issues. The first of these, Acticor Biotech, develops an antibody inhibitor of arterial thrombosis, directed against the glycoprotein 6 (GP6), a new therapeutic target on the surface of platelets.[…]”

Full article : http://labiotech.eu/biotechs-crowdfunding-france-top-class/